Schedules of Controlled Substances: Placement of Eluxadoline Into Schedule IV. Final rule.
Fed Regist
; 80(218): 69861-4, 2015 Nov 12.
Article
en En
| MEDLINE
| ID: mdl-26567437
With the issuance of this final rule, the Administrator of the Drug Enforcement Administration places the substance 5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid (eluxadoline), including its salts, isomers, and salts of isomers, into schedule IV of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule IV controlled substances on persons who handle (manufacture, distribute, dispense, import, export, engage in research, conduct instructional activities, or possess) or propose to handle eluxadoline.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Fenilalanina
/
Fármacos Gastrointestinales
/
Control de Medicamentos y Narcóticos
/
Imidazoles
Límite:
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Fed Regist
Año:
2015
Tipo del documento:
Article
Pais de publicación:
Estados Unidos